95
DIETZ, B.M., MAHADY, G.B., PAULI, G.F., FARNSWORTH, N.R. Valerian extract
and valerenic acid are partial agonists of the 5-HT
5a
receptor in vitro. Mol Brain
Res., 138, 191-197, 2005.
DUMORTIER, G., CABARET, W., STAMATIADIS, L., SABA, G., BENADHIRA,
R., ROCAMORA, J.F., AUBRIOT-DELMAS, B., GLIKMAN, J., JANUEL, D.
Hepatic tolerance of atypical antipsychotic drugs. Encephale, 28, 542-551, 2002.
EGAN, M.F., APUD, J., WYATT, R.J. Treatment of tardive dyskinesia. Schiz Bull., 23,
583–609, 1997.
EGHBAL, M.A., TAFAZOLI, S., PENNEFATHER, P., O'BRIEN, P.J. Peroxidase
catalysed formation of cytotoxic prooxidant phenothiazine free radicals at
physiological pH. Chem Biol Interac., 151, 43-51, 2004.
EISENBERG, D.M., DAVIS, R.B., ETTNER, S.L., APPEL, S., WILKEY, S.,
ROMPAY, M.V., KESSLER, R. Trends in alternative medicine use in United
States, 1990-1997: results of a follow-up national survey. JAMA, 280, 1569-1575,
1998.
FACHINETTO, R., VILLARINHO, J.G., WAGNER, C., PEREIRA, R.P., ÁVILA,
D.S., BURGER, M.E., CALIXTO, J.B., ROC HA, J.B., FERREIRA, J. Valeriana
officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role
of dopamine transporter. Prog NeuroPsychopharmacol Biol Psychiatry, 31, 1478-
1486, 2007.
FANG, J., MCKAY, G., SONG, J., REMILLRD, A., LI, X., MIDHA, K. In vitro
characterization of the metabolism of haloperidol using recombinant cytochrome
P450 enzymes and human liver microsomes. Drug Metab Dispos., 12, 1638–1643,
2001.
FARINA, M., BARBOSA, N.B.V., NOGUEIRA, C.W., FOLMER, V., ZENI, G.,
ANDRADE, L.H., BRAGA, A.L., ROCHA, J.B.T. Reaction of diphenyl diselenide
with hydrogen peroxide and inhibition of delta-aminolevulinate dehydratase from
rat liver and cucumber leaves. Braz J Med Biol Res., 35, 623-631, 2002.
FIBIGER, H.C., LLOYD, K.G. Neurobiological substrates of tardive dyskinesia: the
GABA hypothesis. Trends Neurosci., 7, 462–464, 1984.